127 related articles for article (PubMed ID: 38242344)
1. CEBPA facilitates LOXL2 and LOXL3 transcription to promote BCL-2 stability and thus enhances the growth and metastasis of lung carcinoma cells in vitro.
Fan L; Jiang W; Chen C; Gao H; Shi J; Wang D
Exp Cell Res; 2024 Feb; 435(2):113937. PubMed ID: 38242344
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of lysyl oxidase-like 2 (LOXL2) is associated with disease progression in lung adenocarcinomas.
Zhan P; Shen XK; Qian Q; Zhu JP; Zhang Y; Xie HY; Xu CH; Hao KK; Hu W; Xia N; Lu GJ; Yu LK
Med Oncol; 2012 Jun; 29(2):648-55. PubMed ID: 21519871
[TBL] [Abstract][Full Text] [Related]
3. LOXL3 Function Beyond Amino Oxidase and Role in Pathologies, Including Cancer.
Laurentino TS; Soares RDS; Marie SKN; Oba-Shinjo SM
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31340433
[TBL] [Abstract][Full Text] [Related]
4. LOXL3-promoted hepatocellular carcinoma progression via promotion of Snail1/USP4-mediated epithelial-mesenchymal transition.
Li R; Shang R; Li S; Ren Y; Shen L; Yang L; Chen S; Chen X; Li J; Xu M
Environ Toxicol; 2022 Oct; 37(10):2540-2551. PubMed ID: 35841383
[TBL] [Abstract][Full Text] [Related]
5. Loxl2 and Loxl3 Paralogues Play Redundant Roles during Mouse Development.
Santamaría PG; Dubus P; Bustos-Tauler J; Floristán A; Vázquez-Naharro A; Morales S; Cano A; Portillo F
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628534
[TBL] [Abstract][Full Text] [Related]
6. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
[TBL] [Abstract][Full Text] [Related]
7. Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas.
Peinado H; Moreno-Bueno G; Hardisson D; Pérez-Gómez E; Santos V; Mendiola M; de Diego JI; Nistal M; Quintanilla M; Portillo F; Cano A
Cancer Res; 2008 Jun; 68(12):4541-50. PubMed ID: 18559498
[TBL] [Abstract][Full Text] [Related]
8. Significance of the Lysyl Oxidase Members Lysyl Oxidase Like 1, 3, and 4 in Gastric Cancer.
Kasashima H; Yashiro M; Okuno T; Miki Y; Kitayama K; Masuda G; Kinoshita H; Morisaki T; Fukuoka T; Hasegawa T; Sakurai K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Hirakawa K; Ohira M
Digestion; 2018; 98(4):238-248. PubMed ID: 30045039
[TBL] [Abstract][Full Text] [Related]
9. A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression.
Peinado H; Del Carmen Iglesias-de la Cruz M; Olmeda D; Csiszar K; Fong KS; Vega S; Nieto MA; Cano A; Portillo F
EMBO J; 2005 Oct; 24(19):3446-58. PubMed ID: 16096638
[TBL] [Abstract][Full Text] [Related]
10. Lysyl Oxidase-like Protein LOXL2 Promotes Lung Metastasis of Breast Cancer.
Salvador F; Martin A; López-Menéndez C; Moreno-Bueno G; Santos V; Vázquez-Naharro A; Santamaria PG; Morales S; Dubus PR; Muinelo-Romay L; López-López R; Tung JC; Weaver VM; Portillo F; Cano A
Cancer Res; 2017 Nov; 77(21):5846-5859. PubMed ID: 28720577
[TBL] [Abstract][Full Text] [Related]
11. Lysyl oxidase-like 2 is a regulator of angiogenesis through modulation of endothelial-to-mesenchymal transition.
de Jong OG; van der Waals LM; Kools FRW; Verhaar MC; van Balkom BWM
J Cell Physiol; 2019 Jul; 234(7):10260-10269. PubMed ID: 30387148
[TBL] [Abstract][Full Text] [Related]
12. Specific protein 1(SP1) regulates the epithelial-mesenchymal transition via lysyl oxidase-like 2(LOXL2) in pancreatic ductal adenocarcinoma.
Kim IK; Lee YS; Kim HS; Dong SM; Park JS; Yoon DS
Sci Rep; 2019 Apr; 9(1):5933. PubMed ID: 30976063
[TBL] [Abstract][Full Text] [Related]
13. Clinical Implications of Lysyl Oxidase-Like Protein 2 Expression in Pancreatic Cancer.
Tanaka N; Yamada S; Sonohara F; Suenaga M; Hayashi M; Takami H; Niwa Y; Hattori N; Iwata N; Kanda M; Tanaka C; Kobayashi D; Nakayama G; Koike M; Fujiwara M; Fujii T; Kodera Y
Sci Rep; 2018 Jun; 8(1):9846. PubMed ID: 29959362
[TBL] [Abstract][Full Text] [Related]
14. Increased lysyl oxidase-like 2 associates with a poor prognosis in non-small cell lung cancer.
Zhan P; Lv XJ; Ji YN; Xie H; Yu LK
Clin Respir J; 2018 Feb; 12(2):712-720. PubMed ID: 27860390
[TBL] [Abstract][Full Text] [Related]
15. MCF-7 cells expressing nuclear associated lysyl oxidase-like 2 (LOXL2) exhibit an epithelial-to-mesenchymal transition (EMT) phenotype and are highly invasive in vitro.
Moon HJ; Finney J; Xu L; Moore D; Welch DR; Mure M
J Biol Chem; 2013 Oct; 288(42):30000-30008. PubMed ID: 24014025
[TBL] [Abstract][Full Text] [Related]
16. LOXL2 promotes oncogenic progression in alveolar rhabdomyosarcoma independently of its catalytic activity.
Almacellas-Rabaiget O; Monaco P; Huertas-Martinez J; García-Monclús S; Chicón-Bosch M; Maqueda-Marcos S; Fabra-Heredia I; Herrero-Martín D; Rello-Varona S; de Alava E; López-Alemany R; Giangrande PH; Tirado OM
Cancer Lett; 2020 Apr; 474():1-14. PubMed ID: 31911079
[TBL] [Abstract][Full Text] [Related]
17. LOXL 2 Promotes The Epithelial-Mesenchymal Transition And Malignant Progression Of Cervical Cancer.
Tian J; Sun HX; Li YC; Jiang L; Zhang SL; Hao Q
Onco Targets Ther; 2019; 12():8947-8954. PubMed ID: 31802904
[TBL] [Abstract][Full Text] [Related]
18. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
Hong X; Yu JJ
Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
[TBL] [Abstract][Full Text] [Related]
19. Systematic screening of lysyl oxidase-like (LOXL) family genes demonstrates that LOXL2 is a susceptibility gene to intracranial aneurysms.
Akagawa H; Narita A; Yamada H; Tajima A; Krischek B; Kasuya H; Hori T; Kubota M; Saeki N; Hata A; Mizutani T; Inoue I
Hum Genet; 2007 May; 121(3-4):377-87. PubMed ID: 17287949
[TBL] [Abstract][Full Text] [Related]
20. LncRNA CEBPA-DT promotes liver cancer metastasis through DDR2/β-catenin activation via interacting with hnRNPC.
Cai Y; Lyu T; Li H; Liu C; Xie K; Xu L; Li W; Liu H; Zhu J; Lyu Y; Feng X; Lan T; Yang J; Wu H
J Exp Clin Cancer Res; 2022 Dec; 41(1):335. PubMed ID: 36471363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]